<DOC>
	<DOCNO>NCT02248077</DOCNO>
	<brief_summary>This study design demonstrate outcome complete ulcer closure patient Wagner Grade 1-4 DFUs , VLUs Stage II-IV PUs use AutoloGel versus Usual Customary Care ( UCC ) .</brief_summary>
	<brief_title>A Prospective , Randomized , Controlled , Multi-Center , Study Evaluating AutoloGel Therapy Complete Closure Wagner Grade 1-4 Diabetic Foot Ulcers , Venous Leg Ulcers Stage II-IV Pressure Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Pressure Ulcer</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<criteria>For DFU indication : 1 . Medicare beneficiary 2 . Males females ≥ 18 year age 3 . Type I II diabetes require medical treatment determine physician 4 . The single wound apply Study Treatment ( Index Ulcer ) Wagner 14 DFU ( see Section 17.12 Appendix 12 Wagner Classification ) locate dorsal , plantar , medial , lateral aspect foot ( include toe surface heel ) 5 . Patients treat UCC center 2 week prior randomization great 20 % reduction wound area volume document wound measurement available 6 . For patient multiple potential Index DFUs , large ulcer select . There must least 4 cm Index Ulcer ulcer ; ulcer closer 4 cm , patient enrol ( screen failure ) 7 . Demonstrated offload regimen 8 . A wound age ≥ 30 day Screening Visit 9 . Patient must willing comply protocol , assess enrol clinician . 10 . Patient must sign Informed Consent Form prior studyrelated procedure . For VLU indication : 1 . Medicare beneficiary 2 . Males females ≥ 18 year age 3 . Diagnosed venous disease 4 . Patients see center/site 2 week prior randomization great 20 % reduction wound area volume document wound measurement available 5 . The nonhealing wound locate knee ankle may include ankle 6 . For patient multiple potential Index VLUs , large ulcer select . There must least 4 cm Index Ulcer ulcer ; ulcer closer 4 cm , patient enrol ( screen failure ) 7 . Demonstrated compression regimen 8 . A wound age ≥ 30 day Screening visit 9 . Patient must willing comply protocol , assess enrol clinician 10 . Patient must sign Informed Consent prior studyrelated procedure . For PU indication : 1 . Medicare beneficiary 2 . Males females ≥ 18 year age 3 . Ulcer pressure/shear etiology ( Stage II , III , IV , see Section 17.13 Appendix 13 stage definition ) 4 . Patients see site 2 week prior randomization great 20 % reduction wound area volume document wound measurement available 5 . The single wound apply Study Treatment ( Index Ulcer ) locate heel , ischium , sacrum , coccyx trochanter 6 . For patient multiple potential PUs , large ulcer select . There must least 4 cm Index Ulcer ulcer ; ulcer closer 4 cm , patient enrol ( screen failure ) 7 . Demonstrated pressure relief regimen 8 . A wound age ≥ 30 day Screening visit 9 . Patient must willing comply Protocol , assess enrol clinician . 10 . Patient must sign Informed Consent prior studyrelated procedure . 1 . Patients know sensitive AutoloGel component ( calcium chloride , thrombin , ascorbic acid ) and/or material bovine origin 2 . Presence another wound concurrently treat might interfere treatment Index wind 3 . Malignancy wind bed 4 . Active clinical wound infection . 5 . Patient inadequate venous access repeat blood draw require AutoloGel process 6 . Patients cognitively impaired healthcare proxy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>